FATE earnings
Fate Therapeutics (FATE) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
- FATE beat EPS estimates in 13 of its last 13 reports.
FATE earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Nov 5, 2026 | -0.25 | -0.27 | 7.45% | $0.00 |
| Q2 2026 | Aug 13, 2026 | -0.25 | -0.25 | 1.44% | $2.08M |
| Q1 2026 | May 13, 2026 | -0.26 | -0.29 | 10.34% | $1.30M |
| Q4 2025 | Feb 26, 2026 | -0.27 | -0.27 | 0.00% | $1.37M |
| Q3 2025 | Nov 13, 2025 | -0.27 | -0.29 | 6.90% | $1.74M |
| Q2 2025 | Aug 12, 2025 | -0.29 | -0.35 | 17.14% | $1.91M |
| Q1 2025 | May 13, 2025 | -0.32 | -0.39 | 17.95% | $1.63M |
| Q4 2024 | Mar 5, 2025 | -0.44 | -0.44 | 0.00% | $1.86M |
| Q3 2024 | Nov 12, 2024 | -0.40 | – | – | $3.07M |
| Q2 2024 | Aug 13, 2024 | -0.33 | – | – | $6.77M |
| Q1 2024 | May 9, 2024 | -0.47 | -0.47 | 0.00% | $1.93M |
| Q4 2023 | Feb 26, 2024 | -0.45 | -0.57 | 21.05% | $1.68M |
| Q3 2023 | Nov 8, 2023 | -0.46 | -0.59 | 22.03% | $1.94M |
| Q2 2023 | Aug 8, 2023 | -0.54 | – | – | $933.00K |
| Q1 2023 | May 3, 2023 | -0.19 | -0.55 | 65.45% | $58.98M |
| Q4 2022 | Feb 28, 2023 | -0.58 | – | – | $44.36M |
| Q3 2022 | Nov 3, 2022 | -0.86 | -0.93 | 7.53% | $14.98M |